CI — The Cigna Group stock price and chart

The Cigna GroupStock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.1% · Russell 1000 0.1% · US Stock Market 0.1% · Russell 3000 0.10% · MSCI World 0.08% · MSCI ACWI 0.08%

$280.76-0.05%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

150.0200.0250.0300.0350.0020.0M40.0M$280.76

2026-09-11

Price$280.76

MA20$282.40

MA50$282.94

Vol8.9M

What would $1,000 invested in CI be worth today? →

CI returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $280.76
Change YTD: +3.74%
Next earnings: Oct 29, 2026
Market cap: 74.2B2018-03 42.8B2026-09 74.2B+73.4% over the window
Enterprise value: 99.2B
Shares outstanding: 264.2M2016-12 259.6M2026-06 264.2M+1.8% over the window
52W low: $239.51
52W high: $315.47
From 52W high: -11.00%
From 52W low: +17.22%
52W range: 54%
Beta: 0.31

Volume

Rel volume: 0.79×
30D volume: 1.7M
30D $ vol: 468.9M

Fundamentals

Sales (ttm): 282.4B2016-12 39.8B2026-06 282.4B+608.8% over the window
Sales/share: $1,068.662016-12 $153.432026-06 $1,068.66+596.5% over the window
EPS (ttm): $24.182016-12 $7.192026-06 $24.18+236.4% over the window
FCF (ttm): 8.6B2016-12 3.6B2019-12 8.4B+136.6% over the window
FCF/share: $32.362016-12 $13.732019-12 $22.67+65.1% over the window
Book value/share: $161.292016-12 $52.782026-06 $161.29+205.6% over the window
Net margin: 2.27%2016-12 4.6%2026-06 2.3%-50.9% over the window
ROE: 15.05%2016-12 13.4%2026-06 15.1%+11.9% over the window
ROA: 4.08%2017-12 3.6%2026-06 4.1%+13.0% over the window
Debt / equity: 0.68×2017-12 0.382026-06 0.68+80.0% over the window
Current ratio: 0.852017-12 0.852026-06 0.85-0.0% over the window

Growth (CAGR, ttm) · 10Y

Sales: +7.78%2025-06-30 → 2026-06-30262B → 282.4B (+7.8% total)+14.90%2023-06-30 → 2026-06-30186.1B → 282.4B (+51.7% total)+11.11%2021-06-30 → 2026-06-30166.8B → 282.4B (+69.3% total)+22.91%2016-12-31 → 2026-06-3039.8B → 282.4B (+608.8% total)
Net income: +51.91%2024-12-31 → 2026-06-303.4B → 6.4B (+86.8% total)-1.57%2022-12-31 → 2026-06-306.8B → 6.4B (-5.4% total)-4.76%2021-06-30 → 2026-06-308.2B → 6.4B (-21.6% total)+14.04%2016-12-31 → 2026-06-301.8B → 6.4B (+248.1% total)
FCF: +160.35%2018-12-31 → 2019-12-313.2B → 8.4B (+160.2% total)+33.28%2016-12-31 → 2019-12-313.6B → 8.4B (+136.6% total)n/an/a
Shares: -1.01%2025-06-30 → 2026-06-30266.9M → 264.2M (-1.0% total)-3.71%2023-06-30 → 2026-06-30296M → 264.2M (-10.7% total)-4.92%2021-06-30 → 2026-06-30340.1M → 264.2M (-22.3% total)+0.18%2016-12-31 → 2026-06-30259.6M → 264.2M (+1.8% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +58.75%2024-12-31 → 2026-06-30$12.12 → $24.18 (+99.5% total)+3.55%2022-12-31 → 2026-06-30$21.41 → $24.18 (+13.0% total)+1.03%2021-06-30 → 2026-06-30$22.98 → $24.18 (+5.2% total)+13.63%2016-12-31 → 2026-06-30$7.19 → $24.18 (+236.4% total)
Sales/share: +8.87%2025-06-30 → 2026-06-30$981.62 → $1,068.66 (+8.9% total)+19.33%2023-06-30 → 2026-06-30$628.88 → $1,068.66 (+69.9% total)+16.86%2021-06-30 → 2026-06-30$490.34 → $1,068.66 (+117.9% total)+22.68%2016-12-31 → 2026-06-30$153.43 → $1,068.66 (+596.5% total)
FCF/share: +165.96%2018-12-31 → 2019-12-31$8.53 → $22.67 (+165.8% total)+18.21%2016-12-31 → 2019-12-31$13.73 → $22.67 (+65.1% total)n/an/a
Book value/share: +7.07%2025-06-30 → 2026-06-30$150.65 → $161.29 (+7.1% total)+1.65%2023-06-30 → 2026-06-30$153.54 → $161.29 (+5.0% total)+2.41%2021-06-30 → 2026-06-30$143.22 → $161.29 (+12.6% total)+12.49%2016-12-31 → 2026-06-30$52.78 → $161.29 (+205.6% total)
Dividend/share: +5.50%2025-06-30 → 2026-06-30$5.82 → $6.14 (+5.5% total)+9.32%2023-06-30 → 2026-06-30$4.70 → $6.14 (+30.6% total)+23.70%2021-06-30 → 2026-06-30$2.12 → $6.14 (+189.6% total)n/a
Price: -8.21%2025-09-11 → 2026-09-11$305.87 → $280.76 (-8.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-0.48%2023-09-11 → 2026-09-11$284.82 → $280.76 (-1.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+6.52%2021-09-10 → 2026-09-11$204.69 → $280.76 (+37.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+8.13%2016-09-09 → 2026-09-11$128.45 → $280.76 (+118.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -6.13%2025-09-11 → 2026-09-11$299.09 → $280.76 (-6.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+1.47%2023-09-11 → 2026-09-11$268.73 → $280.76 (+4.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+8.52%2021-09-10 → 2026-09-11$186.52 → $280.76 (+50.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+9.29%2016-09-09 → 2026-09-11$115.44 → $280.76 (+143.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 11.6×2017-03 20.372026-09 11.56-43.2% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 7.5×2018-03 10.852026-09 7.45-31.3% over the window
Fwd P/E: 8.2×
P/S (ttm)Market cap ÷ TTM revenue.: 0.3×2018-03 1.022026-09 0.26-74.3% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 1.7×2018-03 3.122026-09 1.74-44.2% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 8.7×2018-03 11.842026-09 8.80-25.7% over the window
EV/EBITDA (fy): 7.8×
EV/Sales (ttm): 0.4×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 11.53%2017-12 8.4%2019-12 11.1%+31.2% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 2.19%
Dividend/share (fwd): $6.14
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 264.2M ÷ 266.9M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 1.01%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (1.01%) + dividends paid over that year ($1.6B) ÷ market_cap_at(2025-06-30) ($88.2B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 2.85%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($1.1B) ÷ today's market cap ($74.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 1.43%2017-12 6.1%2026-06 1.4%-76.3% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $1.1B + TTM dividends $1.6B) ÷ today's market cap ($74.2B). Same caveat as the cash buyback yield.: 3.62%2017-12 6.1%2026-06 3.6%-40.0% over the window

Vs own 10Y history

P/E: 15th
P/OI: 3rd
P/S: 3rd
P/B: 40th
P/FCF: 21st

Bar = where today’s multiple sits in CI’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

-0.05%

-1.38%

+1.77%

-4.25%

YTD

+3.74%

-5.06%

+41.86%

Financial statements

Open full CI financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%

The Cigna Group (CI) trades at $280.76 with a live price and an interactive chart covering 44+ years of daily price history, plus key valuation metrics. ChartRow also publishes CI’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full CI financial statements →

CI — The Cigna Group price, chart and key statistics